National Health Investors (NYSE:NHI) Updates FY 2024 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY 2024 earnings guidance on Monday morning. The company provided EPS guidance of 4.370-4.430 for the period, compared to the consensus EPS estimate of 4.350. The company issued revenue guidance of -.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on NHI. Wedbush raised their target price on shares of National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a report on Monday, March 18th. Truist Financial raised their price objective on shares of National Health Investors from $55.00 to $58.00 and gave the company a hold rating in a report on Thursday, April 4th. StockNews.com downgraded shares of National Health Investors from a buy rating to a hold rating in a research note on Thursday, April 18th. Deutsche Bank Aktiengesellschaft began coverage on National Health Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $69.00 price target on the stock. Finally, BMO Capital Markets raised National Health Investors from a market perform rating to an outperform rating and set a $67.00 price target for the company in a report on Tuesday, March 12th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat.com, National Health Investors has an average rating of Hold and an average price target of $60.50.

National Health Investors Stock Performance

Shares of NHI traded down $0.47 during midday trading on Monday, reaching $64.25. 137,247 shares of the stock were exchanged, compared to its average volume of 169,745. National Health Investors has a twelve month low of $48.51 and a twelve month high of $65.23. The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27. The company has a market capitalization of $2.79 billion, a price-to-earnings ratio of 20.68 and a beta of 0.95. The business’s 50-day moving average price is $60.55 and its 200 day moving average price is $56.25.

National Health Investors Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th were given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 5.60%. The ex-dividend date of this dividend was Wednesday, March 27th. National Health Investors’s dividend payout ratio (DPR) is 115.02%.

Insider Buying and Selling at National Health Investors

In other National Health Investors news, Director Charlotte A. Swafford bought 10,000 shares of the stock in a transaction dated Tuesday, February 27th. The shares were acquired at an average cost of $58.69 per share, for a total transaction of $586,900.00. Following the completion of the transaction, the director now owns 110,185 shares in the company, valued at approximately $6,466,757.65. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 8.21% of the stock is owned by company insiders.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.